All stocks Β· VAISHALI
VP

Vaishali Pharma Limited

VAISHALI NSE Drug Manufacturers - Specialty & Generic Healthcare

Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers a portfolio of active pharmaceutical ingredients, such as antibiotics, anti-ulcer, anti-inflammatory, analgesic, ant…

ISIN INE972X01022
Listed 15 Jan 2020
Quarters tracked 4
Filings 12 docs

About

Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers a portfolio of active pharmaceutical ingredients, such as antibiotics, anti-ulcer, anti-inflammatory, analgesic, anti-pyretic, topical steroids, antiΒ–malarial, cardiac, corticosteroids, anti-diabetics, anti-cold, anti-allergic, anti-diarrheal, anti-protozoal, anti-parasitic, excipients, anti-viral, anti-epileptic, anti-asthmatic, enzymes, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helminitic. The company also provides formulations, including antibiotics, antibacterial, anti-platelet, laxative, anti-ulcer, enzymes, anti-asthmatic, anti-malarial, anti-cold, anti-allergic, anti-viral, anti-psychotic, anti-fungal, vitamins, topical steroids, corticosteroids, anti-inflammatory, analgesic, anti-pyretic, anti-diabetic, cardiac, and other products. In addition, it offers disposable surgical and casting tape products; herbal products; veterinary products; nutraceutical products; and oncology products. The company was formerly known as Vaishali Pharma Private Limited. Vaishali Pharma Limited was founded in 1989 and is based in Mumbai, India.

Key Metrics

as of Sep 2026
Market Cap109 Cr
P/E24.30
Div Yield0.00 %
Book Valueβ‚Ή5.30
52w Highβ‚Ή12.70
52w Lowβ‚Ή4.75
Face Valueβ‚Ή2.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025
Sales 22.89 26.93 24.65 33.45
Expenses 21.40 27.13 23.09 32.06
Operating Profit 1.49 -0.20 1.56 1.39
OPM % 6.51 -0.74 6.33 4.16
Other Income 0.58 1.26 0.89 0.84
Depreciation 0.14 0.16 0.13 0.17
Interest 0.20 0.72 0.51 0.40
Profit before tax 1.73 0.18 1.81 1.66
Tax % 13.87 -61.11 28.18 28.31
Net Profit 1.55 0.41 1.32 1.19
EPS in Rs 0.12 0.03 0.10 0.09

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026
Sales 109.00
Expenses 105.00
Operating Profit 4.00
OPM % 3.80
Other Income 4.00
Interest 2.00
Depreciation 1.00
Profit before tax 5.00
Tax % 25.00
Net Profit 4.00
EPS in Rs 0.32
Dividend Payout % 0.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026
Equity Capital 26.00
Reserves 43.00
Borrowings 19.00
Other Liabilities 35.00
Total Liabilities 123.00
Fixed Assets 2.00
CWIP 0.00
Investments 6.00
Other Assets 116.00
Total Assets 123.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026
Debtor Days 170.00
Inventory Days 13.00
Days Payable 81.00
Cash Conversion Cycle 102.00
Working Capital Days 212.00

Shareholding Pattern

% holding β€” latest first
Holder Jul 2026 Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023
Promoters 30.54 31.61 31.61 31.61 26.32 26.32 26.32 26.32 26.32 26.32 26.32 26.62
Public 69.46 68.39 68.39 68.39 73.68 73.68 73.68 73.68 73.67 73.68 73.68 73.38
No. of Shareholders 26,697 26,671 26,534 27,148 27,752 28,682 28,874 27,546 18,983 9,479 9,390 9,181

Corporate Actions

9 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Bonus 15 Oct 2024 15 Oct 2024 1:1 β€”
Split 15 Oct 2024 15 Oct 2024 10:2 β€”
Other 19 Sep 2024 β€” β€” β€” Annual General Meeting
Other 22 Sep 2023 β€” β€” β€” Annual General Meeting
Other 27 Dec 2022 β€” β€” β€” Extra Ordinary General Meeting
Other 23 Sep 2022 β€” β€” β€” Annual General Meeting
Other 22 Sep 2021 β€” β€” β€” Annual General Meeting
Other 28 Jul 2021 β€” β€” β€” Extra Ordinary General Meeting
Other 22 Sep 2020 β€” β€” β€” Annual General Meeting

Announcements

5 filings
  • General Updates
    04 Sep 2026 4 Sep - NSE approved listing of 45,37,865 preferential equity shares, pending depository confirmation.
  • Copy of Newspaper Publication
    03 Sep 2026 3 Sep - Company published newspaper advertisements for its 19th AGM in English and Marathi editions.
  • General Updates
    01 Sep 2026 1 Sep - Book closure from 18-24 Sep 2026; record date 17 Sep 2026 for 19th AGM e-voting.
  • Record Date
    01 Sep 2026 1 Sep - Book closure 18-24 Sep 2026; record date 17 Sep 2026 for Vaishali Pharma's 19th AGM.
  • Shareholders meeting
    01 Sep 2026 1 Sep - 19th AGM on 24 Sept 2026 via VC/OAVM; book closure 18-24 Sept, Jagruti Vasani up for reappointment.